Table 2.

Demographics of individuals tested positive for chronic HCV (HCV Antibody-positive and HCV RNA-positive; monoinfected): HCV pathway vs. usual care.

		HCV Pathway	Usual Care	p-Value
Total 2015–2018	Patients	2122 (100.0%)	620 (100.0%)
	18–19	3 (0.1%)	1 (0.2%)	0.909
	20–29	86 (4.1%)	33 (5.3%)	0.172
	30–39	133 (6.3%)	64 (10.3%)	0.001
	40–49	155 (7.3%)	85 (13.7%)	<0.001
	50–59	757 (35.7%)	203 (32.7%)	0.178
	60–69	892 (42.0%)	190 (30.6%)	<0.001
	70–79	86 (4.1%)	37 (6.0%)	0.043
	80–89	8 (0.4%)	7 (1.1%)	0.026
	90–99	2 (0.1%)	0 (0%)	0.444
	100+	0 (0%)	0 (0%)
Baby boomer	Baby boomer	1646 (77.6%)	400 (64.5%)	<0.001
	Not baby boomer	476 (22.4%)	220 (35.5%)	<0.001
Sex	Female	803 (37.8%)	249 (40.2%)	0.296
	Male	1319 (62.2%)	371 (59.8%)	0.296
Pregnancy	Pregnancy during testing	11 (1.4%)	8 (3.2%)	0.042
Race	American Indian/Alaskan native	11 (0.5%)	6 (1.0%)	0.21
	Asian	114 (5.4%)	71 (11.5%)	<0.001
	Black/African American	1346 (63.4%)	339 (54.7%)	<0.001
	Native Hawaiian/ Pacific islander	3 (0.1)%	0 (0%)	0.349
	Unknown or not reported	68 (3.2%)	26 (4.2%)	0.234
	White/Caucasian	574 (27.0%)	174 (28.1%)	0.618
	Other	6 (0.3%)	4 (0.6%)	0.188
Insurance	Commercial	1251 (59.0%)	405 (65.3%)	0.004
	Medicaid	384 (18.1%)	83 (13.4%)	0.006
	Medicare	463 (21.8%)	125 (20.2%)	0.376
	Other	5 (0.2%)	1 (0.2%)	0.727
	Unknown	19 (0.9%)	6 (1.0%)	0.868
IV drug use	No or unknown	2085 (98.3%)	618 (99.7%)	0.009
	Yes	37 (1.7%)	2 (0.3%)	0.009
Sexual history: men who have sex with men (MSM)	No or unknown	2107 (99.3%)	603 (97.3%)	<0.001
	Yes	15 (0.7%)	17 (2.7%)	<0.001
DAA treatment 1	No treatment	924 (43.5%)	370 (59.7%)	<0.001
	treatment	1198 (56.5%)	250 (40.3%)	<0.001

^1. Direct-acting antiviral.